A leading cardiovascular disease researcher from Simon Fraser University is ringing the alarm on universal recommendations ...

A new study finds a better way to predict heart attack risk: combining the PREVENT risk model with a CT scan of the coronary ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

A new risk calculator accurately identified participants who had calcium buildup in their heart arteries and those who had a higher future heart attack risk, in an analysis of about 7,000 adults in ...

As heart disease remains the leading cause of death in Americans, local physicians are continuing to use new technology to improve heart health. Dr. Jane Schwabe, a cardiothoracic surgeon at Mosaic, ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

In TODAY.com's Expert Tip of the Day, a longevity researcher reveals how much fiber you really need to age well and prevent ...

Heart disease is the leading cause of death in the US, claiming the lives of about 700,000 Americans each year.

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...

The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis ...

Heart Disease Deaths Worldwide Linked to Chemical ... intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to ...

Research has shown a strong association between elevated Lp (a) levels and an increased risk of cardiovascular disease, ...